Technology
Data Service
Pharmaceutical

OptimizeRx

$16.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.85 (5.44%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell OptimizeRx and other stocks, options, ETFs, and crypto commission-free!

About

OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records, which serves as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. Read More The company was founded by David A. Harrell on November 8, 1985 and is headquartered in Rochester, MI.

Employees
37
Headquarters
Rochester, Michigan
Founded
1985
Market Cap
191.92M
Price-Earnings Ratio
544.72
Dividend Yield
0.00
Average Volume
49.71K
High Today
$16.75
Low Today
$15.11
Open Price
$15.11
Volume
96.07K
52 Week High
$18.39
52 Week Low
$7.00

Collections

Technology
Data Service
Pharmaceutical
Healthcare
Finance
Education
Software Service
Health

News

Yahoo FinanceMay 8

OptimizeRx Reports First Quarter 2019 Results; Total Revenue Up 27% to $5.2 Million, Driving Non-GAAP Net Income up 130% to $833,000 or $0.06 per Diluted Share

ROCHESTER, Mich., May 08, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the first quarter ended March 31, 2019. Quarterly comparisons are to the same year-ago quarter. Q1 2019 Financial Highlights Total revenue increased 27% to $5.2 million. Gross margin improved from 51.2% to 69.6%. Net income of $7,000 vs. a loss of $189,000. Non-GAAP net income up 130% to $833,000 or $0.06 per dilut...

13
Yahoo FinanceApr 30

EVERSANA and OptimizeRx Partner to Deliver High Tech and High Touch Pharmaceutical Services

Combined offering integrates EHR network and proactive patient services to improve access and adherence LAS VEGAS, April 30, 2019 /PRNewswire/ -- EVERSANA™, the leading independent provider of global services to the life science industry, and OptimizeRx Corp. (OPRX), a leading digital health messaging platform focused on affordability and adherence, today announced their partnership to modernize the patient experience and improve health outcomes by combining a real-time electronic health records (EHR) ...

8
Markets InsiderApr 29

OptimizeRx Strengthens Executive Leadership with Appointment of Chief Commercial Officer

ROCHESTER, Mich., April 29, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, has appointed Stephen Silvestro to the new position of chief commercial officer. Silvestro will be responsible for driving OptimizeRx’s platform revenue growth, including enterprise level direct-to-patient and direct-to-provider product adoption to improve patient outcomes. “We are thrilled to welcome Steve to the team, as he brings importan...

1

Earnings

-$0.01
$0.01
$0.04
$0.06
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
$0.06 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.